FI941053A0 - A mutated growth factor receptor useful as a drug and its use in the treatment of cancer - Google Patents
A mutated growth factor receptor useful as a drug and its use in the treatment of cancerInfo
- Publication number
- FI941053A0 FI941053A0 FI941053A FI941053A FI941053A0 FI 941053 A0 FI941053 A0 FI 941053A0 FI 941053 A FI941053 A FI 941053A FI 941053 A FI941053 A FI 941053A FI 941053 A0 FI941053 A0 FI 941053A0
- Authority
- FI
- Finland
- Prior art keywords
- cancer
- drug
- treatment
- growth factor
- factor receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19914129533 DE4129533A1 (en) | 1991-09-05 | 1991-09-05 | MUTTED GROWTH FACTOR RECEPTOR AS A MEDICINAL PRODUCT AND ITS USE FOR TREATING CANCER |
PCT/EP1992/002058 WO1993005148A1 (en) | 1991-09-05 | 1992-09-07 | Mutated growth factor receptor as medicament and its use for treating cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
FI941053A0 true FI941053A0 (en) | 1994-03-04 |
FI941053A FI941053A (en) | 1994-04-08 |
Family
ID=6439926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI941053A FI941053A (en) | 1991-09-05 | 1994-03-04 | Mutant plant factor receptor useful as a drug and its use in the treatment of cancer |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0667899A1 (en) |
JP (1) | JPH07502884A (en) |
CN (1) | CN1071586A (en) |
AU (1) | AU669857B2 (en) |
CA (1) | CA2117073A1 (en) |
DE (1) | DE4129533A1 (en) |
FI (1) | FI941053A (en) |
MX (1) | MX9205084A (en) |
NO (1) | NO940778L (en) |
NZ (1) | NZ244239A (en) |
PT (1) | PT100844A (en) |
WO (1) | WO1993005148A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN274295A0 (en) * | 1995-05-02 | 1995-05-25 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
US6465623B2 (en) | 1995-05-02 | 2002-10-15 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
US6790614B1 (en) | 1999-11-19 | 2004-09-14 | Novartis Ag | Selectable cell surface marker genes |
CN104480200B (en) | 2004-03-31 | 2017-12-29 | 综合医院公司 | Determine method of the cancer to EGF-R ELISA magnetic target therapy reactivity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0325224B1 (en) * | 1988-01-22 | 1996-07-31 | ZymoGenetics, Inc. | Methods of producing secreted receptor analogs |
WO1990008160A1 (en) * | 1989-01-20 | 1990-07-26 | Imperial Cancer Research Technology Ltd. | Growth factor receptor-like peptides without tyrosine-kinase activity |
GB9001466D0 (en) * | 1990-01-23 | 1990-03-21 | Erba Carlo Spa | Extracellular form of the human fibroblast growth factor receptor |
CA2055441C (en) * | 1989-05-19 | 2003-01-07 | Robert M. Hudziak | Her2 extracellular domain |
JP2975679B2 (en) * | 1989-09-08 | 1999-11-10 | ザ・ジョーンズ・ホプキンス・ユニバーシティ | Structural change of EGF receptor gene in human glioma |
-
1991
- 1991-09-05 DE DE19914129533 patent/DE4129533A1/en not_active Ceased
-
1992
- 1992-09-04 PT PT10084492A patent/PT100844A/en not_active Application Discontinuation
- 1992-09-04 MX MX9205084A patent/MX9205084A/en unknown
- 1992-09-05 CN CN 92111396 patent/CN1071586A/en active Pending
- 1992-09-07 WO PCT/EP1992/002058 patent/WO1993005148A1/en not_active Application Discontinuation
- 1992-09-07 EP EP92918949A patent/EP0667899A1/en not_active Withdrawn
- 1992-09-07 NZ NZ24423992A patent/NZ244239A/en unknown
- 1992-09-07 CA CA 2117073 patent/CA2117073A1/en not_active Abandoned
- 1992-09-07 AU AU25185/92A patent/AU669857B2/en not_active Ceased
- 1992-09-07 JP JP5504969A patent/JPH07502884A/en active Pending
-
1994
- 1994-03-04 FI FI941053A patent/FI941053A/en not_active Application Discontinuation
- 1994-03-04 NO NO940778A patent/NO940778L/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE4129533A1 (en) | 1993-03-11 |
AU2518592A (en) | 1993-04-05 |
CN1071586A (en) | 1993-05-05 |
MX9205084A (en) | 1993-05-01 |
NO940778D0 (en) | 1994-03-04 |
FI941053A (en) | 1994-04-08 |
EP0667899A1 (en) | 1995-08-23 |
NZ244239A (en) | 1995-07-26 |
JPH07502884A (en) | 1995-03-30 |
NO940778L (en) | 1994-05-04 |
WO1993005148A1 (en) | 1993-03-18 |
AU669857B2 (en) | 1996-06-27 |
CA2117073A1 (en) | 1993-03-18 |
PT100844A (en) | 1994-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69233491D1 (en) | Pharmaceutical composition containing S-nitrosolipoproteins and their use | |
EG19187A (en) | Quinazoline derivatives and their use as fungicide. | |
ATA901392A (en) | HEPATITIS-C DIAGNOSIS AND VACCINE | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
FI944600A (en) | Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy | |
DE69223266D1 (en) | Peptide derivatives and their use | |
IT8768027A0 (en) | DERIVATIVES OF 1 PIPERAZINIL PYRIMIDINE THEIR PREPARATION AND USE IN THERAPY AND COSMETICS | |
DE69230654D1 (en) | Commiphora-Mukul extracts and their therapeutic use | |
GB9022368D0 (en) | Materials useful in human and veterinary medicine | |
DE68910113T2 (en) | GROWTH INHIBITANT AND ITS USE. | |
DE3879811D1 (en) | PHARMACEUTICAL COMPOSITION AND THEIR USE. | |
IL99612A0 (en) | 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy | |
GB9103075D0 (en) | Trinitrobenzene derivatives and their therapeutic use | |
FI940775A0 (en) | process for the preparation of alpha-phenylisoserine derivatives and their use | |
FI941053A0 (en) | A mutated growth factor receptor useful as a drug and its use in the treatment of cancer | |
FI973185A0 (en) | Use of melatonin in the treatment of patients with drug dependence | |
DE69210474T2 (en) | Medical-surgical hygiene articles and materials | |
IL91451A0 (en) | Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction | |
ZA924127B (en) | New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents | |
ZA911956B (en) | 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances | |
DE59108548D1 (en) | Implantable devices and materials | |
ZA924038B (en) | New oxazole derivatives and their preparation and use | |
AU1745092A (en) | Thiazolidine derivatives and their use in therapy | |
DE69121210D1 (en) | THERAPEUTIC USE OF THE FIBROBLAST GROWTH FACTOR | |
DE69100923D1 (en) | Pharmaceutical and / or cosmetic preparation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |